<DOC>
	<DOCNO>NCT02682810</DOCNO>
	<brief_summary>This two-arm , unmasked , randomize , control trial test effectiveness Alere Q point-of-care ( POC ) HIV diagnostic assay use resource-poor setting .</brief_summary>
	<brief_title>Point Care Virologic Testing Improve Outcomes HIV-Infected Children</brief_title>
	<detailed_description>At public sector clinic Lusaka , Zambia , approximately 2,867 HIV-exposed infant 4 12 week life randomize trial point-of-care virologic test improve outcome HIV-infected child Zambia . There standard care ( SOC ) control arm intervention arm know Alere arm . In study arm , early infant diagnosis ( EID ) provide 6 week life . Infants randomize SOC arm receive EID exist prevention mother-to-child-transmission ( PMTCT ) program , sample sent off-site laboratory DNA PCR test . Infants randomize intervention arm receive POC diagnostic Alere Q qualitative test ( along dry blood spot [ DBS ] drawn confirmatory DNA PCR ) . HIV-infected infant follow 12 month .</detailed_description>
	<criteria>4 12 week life document HIV exposure seropositive maternal infant HIV antibody test parent guardian able provide write informed consent participant follow 12 month study enrolment Infants exclude participation major congenital anomaly medical condition would require management referral facility otherwise interfere study procedure</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>12 Weeks</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>point-of-care HIV diagnosis</keyword>
	<keyword>Alere Q</keyword>
	<keyword>diagnostic</keyword>
	<keyword>child</keyword>
</DOC>